Now Reading:

Sanofi gets competition OK for Genzyme


Sanofi gets competition OK for Genzyme


France’s Sanofi Aventis has moved a step closer to taking over American biotech firm Genzyme as US competition regulators have given it the green light.

Sanofi-Aventis has taken its offer for Genzyme directly to shareholders, after management refused to come to the table and discuss a friendly takeover.

If Genzyme’s management continues to refuse to negotiate, there could be a lengthy takeover battle.

Sanofi aims to acquire Genzyme’s lucrative portfolio of drugs for rare diseases as it prepares for the loss of patent protection on top-selling drugs, such as its biggest product, the blood clot preventer Plavix.

Every story can be told in many ways: see the perspectives from Euronews journalists in our other language teams.

Next Article